134 related articles for article (PubMed ID: 19878393)
1. Case of cutaneous malignant melanoma surviving 16 years with late recurrence.
Otsu U; Fukui N; Iki M; Moriwaki S; Kiyokane K
J Dermatol; 2009 Nov; 36(11):598-603. PubMed ID: 19878393
[TBL] [Abstract][Full Text] [Related]
2. Vitiligo: a good prognostic factor in melanoma?
Cunha D; Pacheco FA; Cardoso J
Dermatol Online J; 2009 Feb; 15(2):15. PubMed ID: 19336032
[TBL] [Abstract][Full Text] [Related]
3. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
[TBL] [Abstract][Full Text] [Related]
6. Alopecia areata associated with regression of cutaneous melanoma.
Yousefi M; Payne JR; Barnhill RL
Int J Dermatol; 2006 Mar; 45(3):314-5. PubMed ID: 16533238
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic and neurotropic melanoma.
Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
[TBL] [Abstract][Full Text] [Related]
8. Is there increased risk of local and in-transit recurrence following sentinel lymph node biopsy?
Cerovac S; Mashhadi SA; Williams AM; Allan RA; Stanley PR; Powell BW
J Plast Reconstr Aesthet Surg; 2006; 59(5):487-93. PubMed ID: 16631558
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma.
Califano J; Nance M
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
11. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
Thomas JM; Clark MA
Eur J Surg Oncol; 2004 Aug; 30(6):686-91. PubMed ID: 15256245
[TBL] [Abstract][Full Text] [Related]
12. Management of malignant melanoma.
Kroon BB; Nieweg OE
Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
14. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
[TBL] [Abstract][Full Text] [Related]
15. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy.
Zapas JL; Coley HC; Beam SL; Brown SD; Jablonski KA; Elias EG
J Am Coll Surg; 2003 Sep; 197(3):403-7. PubMed ID: 12946795
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of cutaneous malignant melanoma after more than 20 years.
Bredgaard R; Lock-Andersen J
J Plast Surg Hand Surg; 2011 Apr; 45(2):113-6. PubMed ID: 21504283
[TBL] [Abstract][Full Text] [Related]
17. Late recurrence of malignant melanoma in the duodenum.
Uchiyama S; Imamura N; Ohuchida J; Hiyoshi M; Nagano M; Marutsuka K; Akiyama Y; Chijiiwa K
Hepatogastroenterology; 2008; 55(86-87):1619-21. PubMed ID: 19102354
[TBL] [Abstract][Full Text] [Related]
18. [Surgical management of cutaneous malignant melanoma. Review].
Lavie A; Desouches C; Casanova D; Bardot J; Grob JJ; Legré R; Magalon G
Ann Chir Plast Esthet; 2007 Feb; 52(1):1-13. PubMed ID: 17030081
[TBL] [Abstract][Full Text] [Related]
19. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
[TBL] [Abstract][Full Text] [Related]
20. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
